Given the adiposopathic consequences of obesity that lead to hyperinsulinemia, and given that hyperinsulinemia (a growth factor) may increase cancer risk (Fig. 4), then reducing insulin levels such as through weight reduction may help facilitate a reduced risk for cancer, and improved prognosis for existing cancer. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.